Table 5.
Characteristics at the time of admission for patients with and without adverse renal outcomes
| Parameter | Adverse renal outcomes (n = 21) | Normal kidney function (n = 52) | P |
|---|---|---|---|
| Age (years) | 48.5 (44.8–53.1) | 39.3 (36.08–42.42) | 0.002 |
| Haemoglobin at admission (g/dL)a | 10.5 (8.7–12.1) | 12.3 (11.4–13.2) | 0.034 |
| Stage 3 AKI, n (%) | 17 (81.0) | 44 (84.6) | 0.734 |
| Need for dialysis, n (%) | 16 (76.2) | 37 (71.2) | 0.777 |
| Bite-to-needle time (h)b | 02 (01–3) | 02 (01–04) | 0.621 |
| Total ASV received (vials)b | 14 (10–23) | 16 (10–23) | 0.807 |
| Serum creatinine (at admission) (mg/dL)b | 3.7 (2.0–4.5) | 2.9 (1.1–4.4) | 0.158 |
| Serum albumin (at admission) (g/dL)a | 3.2 (2.9–3.4) | 3.0 (2.9–3.2) | 0.397 |
| Duration of hospitalization (days)b | 19 (9.5–28) | 12.5 (9–18) | 0.040 |
| eGFR 2 weeks post-dischargec | 49.6 (35.6–63.6) | 78 (70.1–85.6) | 0.001 |
a
Mean with CIs.
b
Median with IQR.
c
The median duration was 30 days (IQR 24–35) since the envenomation.